Summary
Stanozolol is an anabolic steroid which is used in the treatment of aplastic anaemia and has been recently advocated for the prophylaxis of vascular thrombosis. Similar steroid substances stimulate the activity of δ-aminolaevulinic acid synthase (ALA S), the rate limiting enzyme of haem biosynthesis, in rat hepatocytes and chick embryo liver cell cultures and activate acute hepatic porphyria. In the present study stanozolol (10 mg daily for 14 days) has been shown to increase significantly leucocyte ALA S activity in 9 healthy male subjects. There was a concomitant rise in urinary ALA and total porphyrin excretion but no change in antipyrine kinetics or urinary 6 B hydroxycortisol excretion. In a complementary study in male Sprague Dawley rats, stanozolol administered intraperitoneally, produced a dose-dependent increase in hepatic ALA S activity without changing hepatic cytochrome P 450 content. Stanozolol has been clearly shown to elevate ALA S activity, probably directly, and, thereby, porphyrin production without affecting hepatic monooxygenase activity. This porphyrinogenic effect may be relevant to the successful treatment of aplastic anaemia with anabolic steroids. Leucocyte ALA S activity may provide a human system for the study of drug porphyrinogenicity in vivo.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Brodie MJ, Goldberg A (1980) Acute hepatic porphyrias. Clin Haematol 4: 253–272
Brodie MJ, Moore MR, Goldberg A (1977A) Enzyme abnormalities in the porphyrias. Lancet 2: 699–701
Brodie MJ, Moore MR, Thompson GG, Goldberg A (1977B) Pregnancy and the acute porphyrias. Br J Obstet Gynaecol 84: 726–731
Brodie MJ, Thompson GG, Moore MR, Beattie AD, Goldberg A (1977C) Hereditary coproporphyria: demonstration of the abnormalities in haem biosynthesis in peripheral blood. Q J Med 182: 299–241
Gordon-Smith EC (1983) Aplastic anaemia and other causes of bone marrow failure. In: Weatherall DJ, Ledingham JGG Warrell DA (eds) Oxford textbook of medicine. Oxford University Press, pp 141–149
Hughes MJ, Rifkind AB (1981) Danazol, a new steroidal inducer of delta-aminolaevulinic acid synthetase. J Clin Endocrinol Metab 52: 549–552
Kappas A (1968) Studies in endocrine pharmacology: biologic actions of some natural steroids on the liver. N Engl J Med 278: 378–384
Kappas A, Levere RD, Granick S (1968) The regulation of porpyrin and heme synthesis. Semin Hematol 5: 323–334
Larson AW, Wassestrom WR, Felsher BF, Shih JC (1978) Post-traumatic epilepsy and acute intermittent porphyria: effects of phenytoin, carbamazepine and clonezepam. Neurology 28: 824–828
McColl KEL, Moore MR, Thompson GG, Goldberg A (1980) Induction of delta-aminoaevulinic acid synthase in leucocytes of patients on phenytoin therapy. Br J Clin Pharmacol 9: 327–331
Moore MR, McColl KEL, Goldberg A (1981) Drugs and the acute porphyrias. TIPS 2: 330–334
Omura T, Sato R (1964) The carbon monoxide-binding pigment of liver microsomes. I Evidence for its haemoprotein nature. J Biol Chem 239: 2370–2378
Ortiz de Montellano PR, Correia MA (1983) Suicidal destruction of cytochrome P 450 during oxidative drug metabolism. Ann Rev Pharmacol Toxicol 23: 481–503
Park BK (1978) A direct radioimmunoassay for 6 B-hydroxycortisol in human urine. J Steroid Biochem 9: 963–969
Park BK, Breckenridge AM (1981) Clinical implications of enzyme-induction and enzyme inhibition. Clin Pharmacokinet 6: 1–24
Rapeport WG, McInnes GT, Thompson GG, Forrest G, Park BK, Brodie MJ (1983) Hepatic enzyme induction and leucocyte delta-aminolaevulinic acid synthase activity: studies with carbamazepine. Br J Clin Pharmacol 16: 133–138
Roberts DT, Brodie MJ, Moore MR, Thompson GG, Goldberg A, McSween RN (1977) Hereditary coproporphyria presenting with photosensitivity induced by the contraceptive pill. Br J. Dermatol 96: 549–553
Shargel L, Cheung W, Yu ABC (1979) High pressure liquid chromatographic analysis of antipyrine in small plasma samaples. J Pharm Sci 68: 1052–1053
Small M, McArdle BM, Lowe GDO, Brodie MJ, Forbes CD, Prentice CRM (1983) Oral stanozolol: effects on plasma and saliva fibrinolysis and plasma viscosity in normal males. Thromb Res 31: 233–237
Small M, McArdle BM, Lowe GDO, Forbed CD, Prentice CRM (1982) The effect of intramuscular stanozolol on fibrinolysis and blood lipids. Thromb Res 28: 27–36
Smith AG, De Matteis F (1980) Drugs and the hepatic porphyrias. Clin Haematology 9: 379–425
Yeung Laiwah AC, Rapeport WG, Thompson GG, MacPhee GJ, Phillips M, Moore MR, Brodie MJ, Goldberg A (1983) Carbamazepine-induced non-hereditary type of acute porphyria. Lancet 1: 790–792
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Thompson, G.G., Small, M., Lowe, G.D.O. et al. Effect of stanozolol on δ-aminolaevulinic acid synthase and hepatic monooxygenase activity in man and rat. Eur J Clin Pharmacol 26, 587–590 (1984). https://doi.org/10.1007/BF00543490
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00543490